One such miniSINEUP, targeting human FXN mRNA, increased frataxin protein to physiological levels and promoted the recovery of disease-associated mitochondrial aconitase defects in Friedreich’s ataxia fibroblasts (Bon et al., 2019). The gene discussed is FXN; the disease is Friedreich ataxia.